Academy of Physicians
in Clinical Research

Academy of Physicians
in Clinical Research




News from SCRIP

APCR Members can get a free trial to SCRIP and a discount on a SCRIP subscription by contacting John Lezcano from SCRIP directly at the information below. 

John Lezcano
Corporate Account Manager

Pharma intelligence | informa
T: (212) 652-2678
M: (631) 807-4971
John.lezcano@informa.com
pharmaintelligence.informa.com

Israel's Medtech Market Evolution: Seeking The Next Big Thing

Mon, 11/26/2018 - 5:54am

Medtronic’s multi-billion-dollar acquisition of Mazor Robotics in 2018 marked a record-breaking milestone for Israel’s life sciences industry as the largest...

      Related Stories 

European Loan Funds F2G's Late-Stage Novel Antifungal

Mon, 11/26/2018 - 5:25am

€24m loan from the European Investment Bank with match funding will progress Phase IIb antifungal Olorofim in invasive aspergillosis. CFO...

      Related Stories 

Severe Asthma Proves Too Much Of A Challenge For Vectura

Mon, 11/26/2018 - 4:49am

An ambitious trial of a budesonide-based drug/device combo for uncontrolled asthma has failed but Vectura is upbeat as it switches...

      Related Stories 

ACT NOW – Cancer Trials At The Leading Edge

Mon, 11/26/2018 - 1:51am

Adoptive Cellular Transfer (ACT): Novel Cancer Trials Demand That Participating Sites Act Differently As more pharma and biotech companies bring their...

      Related Stories 

Multinationals Eye Divesting Established Products In China Amid Fierce Competition, Shifting Focus

Sun, 11/25/2018 - 5:37pm

Farewell established products, hello innovative new drugs! As pricing pressures mount, more multinational companies including Lilly and Roche are switching...

      Related Stories 

Eisai Seeks To Block Dr Reddy’s Over Belviq Plans In India

Fri, 11/23/2018 - 6:46am

Eisai has moved court against Dr Reddy’s for alleged infringement of its patent on Belviq in India. The case is...

      Related Stories 

Pipeline Watch: Phase III Starts With Relacorilant And Invossa

Fri, 11/23/2018 - 6:17am

Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events announced by pharmaceutical and biotech companies at medical...

      Related Stories 

Sweden's Combigene Readies Gene Therapy For Epilepsy Trials

Fri, 11/23/2018 - 6:14am

CombiGene CEO tells Scrip the Swedish biotech seeks a big pharma partner to develop its lead asset CG01 as a...

      Related Stories 

VIDEO: RedHill Unveils Plans For Pivotal Phase III Study For Crohn’s Therapy

Fri, 11/23/2018 - 2:11am

RedHill Biopharma’s study results for its novel antibiotic approach to Crohn’s disease has left the company with some unanswered questions...

      Related Stories 

Luxturna Approved In EU: Novartis Outlines Lessons For Gene Therapy Strategies

Thu, 11/22/2018 - 9:48pm

The European Commission has officially approved Luxturna, Novartis/Spark Therapeutics’ transformative gene therapy. The Swiss firm tells Scrip how the lessons...

      Related Stories 

Valneva/Emergent BioSolutions' Candidate Zika Vaccine Shows Early Clinical Promise

Thu, 11/22/2018 - 6:30am

A European/US company collaboration has reported encouraging safety and immunogenicity in early clinical studies with an alum-adjuvanted Zika vaccine based...

      Related Stories 

VIDEO: Galecto Funnels Funding Into Phase II For Inhaled IPF Therapy

Thu, 11/22/2018 - 2:31am

Galecto Biotech recently raised €79m in a Series C funding round. Chief medical officer Richard Marshall spoke to Scrip about...

      Related Stories 

Pages